pulmonary tuberculosis
Showing NaN - NaN of 7
Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,
Active, not recruiting
- Infections and Infestations
- Pulmonary Tuberculosis
- Delpazolid
- Bedaquiline, Delamanid, Moxifloxacin
-
Tembisa, Gauteng, South Africa
- +4 more
Sep 13, 2022
Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)
Recruiting
- Tuberculosis
- +2 more
- Isoniazid
- +4 more
-
Johannesburg, Gauteng, South AfricaTembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022
Tuberculosis, Pulmonary Tuberculosis Trial in Johannesburg (Pravastatin, Rifafour, Vitamin B6)
Recruiting
- Tuberculosis
- Pulmonary Tuberculosis
- Pravastatin
- +2 more
-
Johannesburg, Gauteng, South AfricaPHRU Non-Network CRS
Oct 29, 2021
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South
Active, not recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +4 more
-
Minsk, Belarus
- +4 more
May 12, 2021
Pulmonary Tuberculosis Trial in South Africa, Tanzania (Moxifloxacin (M), Pretomid (Pa), Pyrazinamide (Z))
Completed
- Pulmonary Tuberculosis
- Moxifloxacin (M)
- +3 more
-
Cape Town, South Africa
- +7 more
May 16, 2018
Pulmonary Tuberculosis Trial in Worldwide (Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin)
Completed
- Pulmonary Tuberculosis
- Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin
-
Beijing, China
- +46 more
Feb 15, 2017